Compared with older growth hormone-releasing peptides, Ipamorelin is often preferred because it is more selective and is less associated with unwanted cortisol or prolactin stimulation
The study used a randomized, 3-period crossover design in ~54 participants, with a single 5 mg dose given in each period at different sites (abdomen, thigh, upper arm) separated by washouts
For instance, some employers choose to exclude GLP-1 drugs from employer-sponsored health plans, some insurance plans require prior authorization before approval, and Medicare does not cover GLP-1s for weight loss
This imbalance can lead to an excess of histamine in the body, which, above a certain amount, can cause a variety of symptoms
doi: 10.3389/fcvm.2021.795750 8 HigginsJPThompsonSG
Clinical Evidence: What Research Shows About Early Semaglutide Results In the STEP trials (Semaglutide Treatment Effect in People with obesity), patients on the highest maintenance dose lost an average of 56% of body weight by week 12